Condition
Post-Treatment Lyme Disease
Total Trials
7
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
Early P 1 (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting4
Enrolling By Invitation1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06915324Not ApplicableRecruitingPrimary
Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
NCT05776251Not ApplicableRecruitingPrimary
taVNS for Persistent Symptoms From Lyme Disease
NCT06611111Early Phase 1RecruitingPrimary
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
NCT05219929Phase 2Enrolling By InvitationPrimary
Tetracycline Treatment Tolerability Trial
NCT05305105Phase 1CompletedPrimary
Effects of Psilocybin in Post-Treatment Lyme Disease
NCT06026969Recruiting
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
NCT04349605Not ApplicableWithdrawnPrimary
Meditation and Kundalini Yoga for Persistent Lyme-related Symptoms - an Online Study
Showing all 7 trials